Combining cholesterol-lowering strategies with imaging data: a visible benefit?

Area of Science:

• Cardiology
• Medical Imaging
• Vascular Biology

Background:

• Coronary artery disease (CAD) presents a global health burden, often with asymptomatic patients, making acute event prediction difficult.
• Atherosclerotic plaque morphology and stability are crucial factors in CAD prognosis.
• Cholesterol-lowering therapies demonstrate beneficial effects on plaque burden, necessitating effective monitoring tools.

Purpose of the Study:

• To review contemporary imaging strategies for characterizing atherosclerotic plaques.
• To evaluate the prognostic value of plaque morphology and stability assessment.
• To explore the role of imaging in monitoring the effectiveness of cholesterol-lowering therapies.

Main Methods:

• Overview of current literature on imaging techniques for atherosclerotic plaques.
• Discussion of coronary angiography, computed tomography, and magnetic resonance imaging limitations.
• Focus on emerging techniques: grey-scale intravascular ultrasound (IVUS), optical coherence tomography (OCT), and near-infrared spectroscopy (NIRS).

Main Results:

• Coronary angiography provides valuable information but involves significant radiation exposure.
• Magnetic resonance imaging (MRI) of coronary vessels is limited by motion artifacts.
• Grey-scale IVUS effectively detects changes in plaque burden, identifies rupture-predictive features, and monitors plaque characteristics during therapy.

Conclusions:

• Imaging plays a vital role in assessing atherosclerotic plaque, aiding in the prediction of acute coronary events.
• Grey-scale IVUS offers significant advantages in evaluating plaque stability and treatment response.
• Future imaging strategies are needed to overcome current limitations and enhance CAD management.